UnitedHealth Group, the nation's largest medical insurer, plans to buy drug benefits manager Catamaran in an effort to contain pharmaceutical drug prices.
The deal is valued at nearly $13 billion, according to USA Today.
For its 35 million customers, Catamaran manages over 400 million prescriptions.
Read more from
USA Today.